E. Goecker
发表
Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates
Cameron R. Wolfe,
M. Hudgens,
R. Baric,
2021,
medRxiv.
M. Wener,
A. Greninger,
C. Morishima,
2021,
medRxiv.
J. Wong,
A. Tsibris,
R. Coombs,
2022,
PloS one.
M. Hudgens,
R. Baric,
Myron S. Cohen,
2021,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
A. Walls,
D. Veesler,
M. Navarro,
2022,
Cell.
A. Walls,
D. Veesler,
M. Navarro,
2021,
bioRxiv.
J. Sagartz,
D. Tyrrell,
L. Corey,
2020,
Molecular therapy. Methods & clinical development.
M. Wener,
Meei-Li W Huang,
A. Greninger,
2021,
Journal of clinical microbiology.
John W. Mellors,
Robert W. Coombs,
Michael M. Lederman,
2012,
Journal of acquired immune deficiency syndromes.
A. Borobia,
H. Schuitemaker,
Andrew Gibson,
2022,
The Lancet Infectious Diseases.
R. Harrington,
J. Golob,
M. Kitahata,
2018,
AIDS.
J. Andriesen,
Yunda Huang,
G. Tomaras,
2023,
PLOS global public health.
Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates
Cameron R. Wolfe,
M. Hudgens,
R. Baric,
2021,
medRxiv.
M. Seaman,
R. Coombs,
P. D’Souza,
2020,
Open forum infectious diseases.
L. Premkumar,
T. Sheahan,
Laura J. Stevens,
2023,
medRxiv.